EDAP TMS SA

FOCL ·Healthcare, Medical Devices, France
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024
Operating Activities
Net Income $-29.2M $-20.6M
Depreciation & Amortization $3.4M $2.8M
Depreciation $2.9M $2.3M
Amortization $304.0K $238.0K
Stock-Based Compensation
Net Cash from Operating Activities $-16.4M $-14.7M
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $-5.7M $-4.5M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $8.6M $5.0M
Net Change in Cash $-10.5M $-17.0M
Free Cash Flow